Stago
2 known investors
Find your way into Stago
Stago develops and manufactures hemostasis testing systems, analyzers, and reagents for clinical and laboratory diagnostics. Its products support blood coagulation and platelet function testing for laboratories, customers, and distributors.
Investors · 2
ARCHIMED Japanlisted by ARCHIMED JapanLyon · $10.8M – $1.1B
How we know: ARCHIMED Japan's portfolio page · Not right? Tell us
La CaissereportedMontréal
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Stago do?
- Stago develops and manufactures hemostasis testing systems, analyzers, and reagents for clinical and laboratory diagnostics. Its products support blood coagulation and platelet function testing for laboratories, customers, and distributors.
- Who are Stago's investors?
- Stago's investors include ARCHIMED Japan, La Caisse.